1) warm blood cardioplegic solution
温血灌注
1.
One is Group I(WBC), who received warm blood cardioplegic solution modified by full or half potassium, and the other is Group II(CCC), who received cold crystalloid cardiopleg.
目的 研究心脏手术麻醉过程中温血灌注液和冷晶体灌注液对心肌的保护作用。
2) continuous tepid blood cardioplegia
微温血灌注
1.
Objective To study the changes in myocardial membrane fluidity during intermittent crystalloid cardioplegia, continuous tepid blood cardioplegia and open-heart operation with beating for congenital heart disease.
目的 应用心肌细胞膜流动性评价间断冷晶体灌注、持续微温血灌注及微温不停跳直视手术技术的心肌保护效果。
3) warm blood cardioplegia perfusion
温氧合血灌注
5) Intermittent warm blood cardioplegia
间断温血灌注
6) terminal warm blood cardioplegia
终末温血灌注
1.
Effect of terminal warm blood cardioplegia on the changes of tubulin in myocardial cells after hypothermic ischemia and reperfusion;
终末温血灌注对低温缺血再灌注心肌细胞微管蛋白的影响
补充资料：离体肝脏血流灌注
离体肝脏血流灌注
extracorporeal hepatic perfusion
见“体外肝脏灌注”。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条